Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

26.26

+0.13 (0.50%)

At close: Sep 9, 2026, 4:00 PM EDT

26.05

-0.21 (-0.80%)

Pre-market: Sep 10, 2026, 7:12 AM EDT

Nurix Therapeutics Financials Overview

Financials in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Revenue	36.77	83.98	54.55	76.99	38.63	29.75
Revenue Growth	-58.40%	53.95%	-29.14%	99.31%	29.84%	66.95%
Gross Profit	-304.17	-232.92	-167.08	-112.16	-145.87	-86.68
Operating Income	-361.18	-285.67	-213.03	-155.06	-183.87	-117.89
Net Income	-341.35	-264.46	-193.57	-143.95	-180.36	-117.19
Earnings Per Share	-3.41	-3.05	-2.88	-2.65	-3.71	-2.73
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Cash & Investments	443.53	592.94	609.58	295.33	373.02	432.91
Total Debt	58.14	55.73	28.3	30.61	11.96	13.04
Net Cash (Debt)	385.39	537.21	581.28	264.72	361.06	419.87
Net Cash Growth	-11.17%	-7.58%	119.59%	-26.68%	-14.01%	49.34%
Net Cash Per Share	3.85	6.20	8.66	4.87	7.43	9.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Operating Cash Flow	-293.7	-249.47	-172.58	-81.37	-159.81	-84.37
Capital Expenditures	-10.82	-14	-9.27	-8.4	-12.24	-5.66
Free Cash Flow	-304.53	-263.47	-181.86	-89.77	-172.05	-90.03
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 31, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
Gross Margin	-	-277.36%	-	-145.69%	-	-291.38%
Operating Margin	-982.37%	-340.16%	-390.52%	-201.41%	-476.01%	-396.25%
Pretax Margin	-929.18%	-314.00%	-354.36%	-186.98%	-466.93%	-393.49%
Profit Margin	-928.44%	-314.90%	-354.85%	-186.98%	-466.93%	-393.93%
FCF Margin	-828.28%	-313.73%	-333.38%	-116.60%	-445.42%	-302.61%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Nov '25 Nov 30, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021
PS Ratio	74.13	21.34	28.71	3.92	15.12	43.22